Status:
COMPLETED
Comparative Safety and Efficacy of Vaginal Misoprostol Versus Lidocaine-prilocaine Cream in Levonorgestrel IUD Insertion
Lead Sponsor:
Cairo University
Conditions:
Contraception
Eligibility:
FEMALE
Phase:
PHASE3
Brief Summary
the aim of the present study is to compare the safety and Efficacy of vaginal misoprostol versus Lidocaine-prilocaine cream in reducing pain during levonorgestrel IUD Insertion in women delivered only...
Eligibility Criteria
Inclusion
- women who delivered only by previous cesarean delivery and requesting LNG-IUD insertion
Exclusion
- women who delivered vaginally, active vaginal or cervical infections and contraindications to IUD insertion or study drugs
Key Trial Info
Start Date :
April 30 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2021
Estimated Enrollment :
210 Patients enrolled
Trial Details
Trial ID
NCT04339348
Start Date
April 30 2020
End Date
March 1 2021
Last Update
May 7 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ahmedsamy
Giza, Egypt, 12511